A new cognitive behavioural approach to the treatment of obesity

被引:170
作者
Cooper, Z [1 ]
Fairburn, CG [1 ]
机构
[1] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England
基金
英国惠康基金;
关键词
obesity; treatment; cognitive behaviour therapy; relapse; weight; body image;
D O I
10.1016/S0005-7967(00)00065-6
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
While behavioural approaches to the management of obesity are often successful in achieving clinically significant weight loss, the weight lost is generally regained. The great majority of patients return to their pre-treatment weight within 3 years. There have been attempts to improve the long-term effectiveness of behavioural treatment but the results have been disappointing. In this paper we suggest that, among other factors, this is because of the neglect of the contribution of cognitive factors to weight regain, and because there is often ambiguity over the goals of treatment. We present a cognitive behavioural analysis of the processes involved in weight regain, and we describe a new cognitive behavioural treatment derived from it. This treatment is designed to minimise the problem of weight regain by addressing psychological obstacles to the acquisition of, and long-term adherence to, effective weight-control behaviour. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:499 / 511
页数:13
相关论文
共 63 条
[1]  
[Anonymous], 1998, Handbook of Obesity
[2]  
[Anonymous], 1997, WHO TECHN REP SER
[3]  
[Anonymous], TREATMENT SERIOUSLY
[4]   PREVENTING RELAPSE IN OBESITY THROUGH POSTTREATMENT MAINTENANCE SYSTEMS - COMPARING THE RELATIVE EFFICACY OF 2 LEVELS OF THERAPIST SUPPORT [J].
BAUM, JG ;
CLARK, HB ;
SANDLER, J .
JOURNAL OF BEHAVIORAL MEDICINE, 1991, 14 (03) :287-302
[5]  
BRAY GA, 1998, HDB OBESITY, P953
[6]  
Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1061
[7]   A DESCRIPTIVE ANALYSIS OF MEN AND WOMEN WHO HAVE LOST SIGNIFICANT WEIGHT AND ARE HIGHLY SUCCESSFUL AT MAINTAINING THE LOSS [J].
COLVIN, RH ;
OLSON, SB .
ADDICTIVE BEHAVIORS, 1983, 8 (03) :287-295
[8]   Valvular heart disease associated with fenfluramine-phentermine [J].
Connolly, HM ;
Crary, JL ;
McGoon, MD ;
Hensrud, DD ;
Edwards, BS ;
Edwards, WD ;
Schaff, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) :581-588
[9]  
COOPER Z, IN PRESS OBESITY THE
[10]  
Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198